2C-T-7: Difference between revisions
| [checked revision] | [pending revision] |
MDElliottMD (talk | contribs) Added empty fda_max parameter to MedTemplate call |
MDElliottMD (talk | contribs) home-claude: Erowid dosing (erowid-claude source; URLs verified; em-dash clean) |
||
| (6 intermediate revisions by 2 users not shown) | |||
| Line 21: | Line 21: | ||
| indications = | | indications = | ||
| dosing = | | dosing = | ||
<titration slug="erowid-dose-oral" author="erowid-claude" | |||
title="Oral dose ladder (Erowid)"> | |||
Erowid's dosage documentation for oral 2C-T-7<ref name="erowid-2ct7-dose"> | |||
Erowid. 2C-T-7 Dosage. Erowid.org. | |||
https://www.erowid.org/chemicals/2ct7/2ct7_dose.shtml. | |||
Accessed 2026-05-25.</ref> reports the following tiers: | |||
* '''Threshold:''' 3-5 mg | |||
* '''Light:''' 10-20 mg | |||
* '''Common:''' 15-30 mg | |||
* '''Strong:''' 10-50 mg | |||
* '''Heavy:''' 25-60 mg | |||
Onset 20 to 140 minutes depending on preparation form and stomach | |||
contents; duration 6 to 12 hours. | |||
</titration> | |||
<titration slug="erowid-dose-insufflated" author="erowid-claude" | |||
title="Insufflated dose ladder (Erowid) -- SAFETY WARNING"> | |||
Insufflated tiers reported by Erowid (CAUTION: multiple fatalities | |||
documented):<ref name="erowid-2ct7-dose"/> | |||
* '''Threshold:''' 1-3 mg | |||
* '''Light:''' 2-10 mg | |||
* '''Common:''' 5-15 mg | |||
* '''Strong:''' 5-20 mg | |||
* '''Heavy:''' 7-25+ mg | |||
Onset 5 to 60 minutes; duration 2 to 5 hours. Erowid documents fatal | |||
incidents associated with insufflated doses in the 30-35 mg range. | |||
Erowid's guidance: "dosages this small must be measured very very | |||
carefully." The safety margin for insufflated 2C-T-7 is narrow. | |||
</titration> | |||
| effects = | | effects = | ||
| interactions = <pharmaInteractions/> | |||
| interactions = | |||
| pregnancy_details = | | pregnancy_details = | ||
| monitoring = | | monitoring = | ||
| Line 32: | Line 64: | ||
}} | }} | ||
[[Category: | |||
[[Category:Research chemicals]] | |||
[[Category:Phenethylamines]] | |||
[[Category:2C-x series]] | |||
[[Category:Classical Psychedelics (Serotonergic)]] | |||
[[Category:Psychedelics]] | |||
Latest revision as of 16:09, 26 May 2026
Research material, Phenethylamine, Classic Psychedelic
2C-T-7
Experience
No personal reports yet
No clinical reports yet
Log in to add your own experience.
Problems
No problems yet. Be the first to suggest one.
+ Add a problemTitration strategies
Oral dose ladder (Erowid)0
Erowid's dosage documentation for oral 2C-T-7[1] reports the following tiers:
- Threshold: 3-5 mg
- Light: 10-20 mg
- Common: 15-30 mg
- Strong: 10-50 mg
- Heavy: 25-60 mg
Onset 20 to 140 minutes depending on preparation form and stomach
contents; duration 6 to 12 hours.Insufflated dose ladder (Erowid) -- SAFETY WARNING0
Insufflated tiers reported by Erowid (CAUTION: multiple fatalities
documented):[1]
- Threshold: 1-3 mg
- Light: 2-10 mg
- Common: 5-15 mg
- Strong: 5-20 mg
- Heavy: 7-25+ mg
Onset 5 to 60 minutes; duration 2 to 5 hours. Erowid documents fatal incidents associated with insufflated doses in the 30-35 mg range. Erowid's guidance: "dosages this small must be measured very very
carefully." The safety margin for insufflated 2C-T-7 is narrow.Effects
No effects listed yet. Be the first to suggest one.
Interactions
No interactions reported yet.
Relevant anecdote
No anecdotes yet. Share a relevant one.
Relevant Literature
No literature entries yet.
Log in to submit relevant literature.
Summary
Classes
Research material, Phenethylamine, Classic Psychedelic
Common uses
Pharmacy
Pharmacology
Purported mechanism
5-HT2A agonist; MAO inhibitor
- ↑ 1.0 1.1 Erowid. 2C-T-7 Dosage. Erowid.org. https://www.erowid.org/chemicals/2ct7/2ct7_dose.shtml. Accessed 2026-05-25.